Citations with the tag: HIV (Viruses)

Results 51 - 100

  • New surgeon general's AIDS report provides updated information.
     // Public Health Reports; Sep/Oct93, Vol. 108 Issue 5, p654 

    Looks at topics addressed in `The Surgeon General's Report on HIV and AIDS,' and updated version of the Public Health Service's 1986 report. Reports discussion of the impact of AIDS on adolescents and the greater impact of AIDS on some minorities; How to order the report; More.

  • Blood money.
     // New Scientist; 3/28/92, Vol. 133 Issue 1814, p19 

    Reveals that French hemophiliacs infected with HIV after receiving contaminated blood products will begin to receive compensation next month. Amount of money to be claimed; More than 500 people have already applied for compensation.

  • Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates.
    Weber, R.; Bryan, R.T. // New England Journal of Medicine; 1/16/92, Vol. 326 Issue 3, p161 

    Details the development of a new method to detect microsporidia spores in feces and duodenal aspirates. Past method of diagnosis which involved invasive measures; Infection with Enterocytozoon bieneusi and chronic diarrhea in patients infected with the human immunodeficiency virus (HIV); More.

  • HIV cases on the rise in Deep South.
    Weber, R.; Bryan, R.T. // Gay & Lesbian Times; 7/24/2008, Issue 1074, p20 

    The article reports on the increase of HIV cases in the Deep South region in the U.S.

  • Fighting AIDS with facts.
    Weber, R.; Bryan, R.T. // New Scientist; 12/16/95, Vol. 148 Issue 2008, p11 

    Reports that despite the fact that two million South Africans are probably HIV infected, they believe that AIDS is not a big problem in South Africa as in Zimbabwe and Zambia. Transvaal Museum's AIDS gallery exhibition; Four languages notes; Taped commentaries plan.

  • Making HIV therapy more manageable.
    Cerrato, Paull L. // RN; Mar98, Vol. 61 Issue 3, p78 

    Gives information on a combination formula of drugs for human immunodeficiency virus. Identification of the formula; Reference to the formula reducing the complex dosage of medication.

  • Cell heresy upsets AIDS theorists.
    Day, Michael // New Scientist; 12/7/96, Vol. 152 Issue 2059, p20 

    Reveals the findings of the Dutch scientists from the University of Amsterdam regarding the impact of the human immunodeficiency viruses (HIV) on the immune system. Effect of the HIV on the CD4 cells; Contrasting findings of the Aaron Diamond AIDS Research Center; Impact of the findings on the...

  • First test kit for HIV-2 virus.
    Day, Michael // FDA Consumer; Jul/Aug90, Vol. 24 Issue 6, p5 

    Reports that the Food and Drug Administration has licensed the first test kit for detecting HIV-2 (human immunodeficiency virus type 2). Details of HIV-2 infection and new test.

  • NICHD says IVIG helpful to HIV-infected children.
    Day, Michael // FDA Consumer; Apr91, Vol. 25 Issue 3, p7 

    Reports that monthly administration of intravenous immune globulin (IVIG) reduces serious bacterial infections and hospitalization in children infected with human immunodeficiency virus, according to the National Institute of Child Health and Human Development (NICHD). Research details.

  • Research on treating HIV in minorities.
    Day, Michael // FDA Consumer; May91, Vol. 25 Issue 4, p7 

    Announces that a program to encourage research on therapies to treat HIV infection in minorities has been started by the National Institute of Allergy and Infectious Diseases (NIAID). Awarding of grants; Figures of minorities with HIV infections and AIDS.

  • Guidelines set for HIV-infected health workers.
    Day, Michael // FDA Consumer; Oct91, Vol. 25 Issue 8, p7 

    Comments on new guidelines concerning HIV-infected health workers issued by the US Department of Health and Human Services. Physicians, dentists, and other health-care workers who are infected with HIV, the virus that causes AIDS, should not perform `exposure-prone' medical procedures unless...

  • High schoolers' practices risky business.
    Day, Michael // FDA Consumer; Jul/Aug92, Vol. 26 Issue 6, p7 

    Reports that more than half of high school students in the United States put themselves at risk for contracting HIV, the virus that causes AIDS, according to a study recently published by the national Centers for Disease Control. The 1990 CDC Youth Risk Behavior Survey, published in the April...

  • The AIDS file.
    Davis, L. // Health (Time Inc. Health); Feb92, Vol. 6 Issue 1, p20 

    Discusses how it's been difficult for researchers to come up with a reliable estimate of the rate of HIV infection in teens, and shows many ways they are attempting to do so. Worrisome implications; Findings; `Incomplete' infections; More.

  • Vertical transmission of HIV in New York State: A basis for...
    Charbonneau, Tina T.; Wade, Nancy A. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p227 

    Highlights a three year prospective study of vertical transmission which was conducted on infants of human immunodeficiency virus-infected (HIV) mothers. Reference to fifty-six infants which have laboratory and clinical evidence of HIV infection; Details of the study.

  • Genital dermatology in the HIV-infected patient.
    Helton, Jennifer L. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p237 

    Presents a summary of common genital dermatologic conditions seen in the human immunodeficiency virus-infected (HIV) patient, which often differs in clinical presentation from that seen in the normal host, with emphasis on diagnosis and treatment. Diagnosis and symptoms of the herpes simplex...

  • Programs to reduce HIV risk behaviors among gay men hinge on social networks.
    Makulowich, Gail S. // AIDS Patient Care & STDs; Aug97, Vol. 11 Issue 4, p297 

    Focuses on the programs used to reduce Human Indeficiency Virus (HIV) risk behaviors among gay men. Impact of these programs on social networks; Reference made to the figures of certain states in the United States; Details on the role of ethnicity in this procedure; Information on the program...

  • Mystery syndrome.
    Makulowich, Gail S. // New Scientist; 10/3/92, Vol. 136 Issue 1841, p11 

    Reports that a search conducted by the WHO in developing countries has so far revealed fewer than 20 cases of the unexplained HIV-negative immune deficiency syndrome. Number of confirmed cases in the United States has risen to 47, up from 30 in August; Worldwide there are fewer than 100;...

  • INDIANA: Health officials urge blacks to be tested for AIDS.
    Makulowich, Gail S. // Gay & Lesbian Times; 11/12/2009, Issue 1142, p18 

    The article reports on the initiation of a Statewide HIV Awareness Program by the Department of Health, the Indiana Family and Social Services Administration and the Indiana Minority Health Coalition in November 2009 in Indianapolis, Indiana.

  • HIV destroys cells long before onset of AIDS.
    Makulowich, Gail S. // New Scientist; 11/7/92, Vol. 136 Issue 1846, p7 

    Reports on research by Anthony Fauci, head of the United State government's AIDS research efforts at the National Institutes of Health, who has found that the AIDS virus invades and destroys key components of the immune system after a person has been infected. Clues from a mouse with a human...

  • AIDS exports.
    Makulowich, Gail S. // New Scientist; 11/7/92, Vol. 136 Issue 1846, p11 

    Reveals that the Institut Merieux, a subsidiary of the French chemicals firm Rhone-Poulenc, has announced that in 1985 it exported blood products that were not heat-treated to destroy HIV. About 3.2 million units of Factor 8 were exported; Countries that received the blood products;...

  • Editorial.
    Kay, Thelma // Asia-Pacific Population Journal; Dec2007, Vol. 22 Issue 3, p2 

    An introduction to the journal is presented in which the editor discusses an article on the demographic impact of HIV/AIDS in Papua New Guinea, population issues, and reproductive health programmes.

  • A TIMELINE.
    Kay, Thelma // Xtra (Toronto); 5/31/2012, Issue 720, p20 

    The article chronicles events concerning HIV/AIDS and Toronto People with AIDS Foundation (PWA) in Ontario including the establishment of the PWA Coalition in 1986, released of the first anti-HIV drug, AZT in 1987 and opening of the fifth international AIDS Conference in Montreal, Quebec in 1989.

  • NYC new HIV cases 3 times national rate.
    Kay, Thelma // Gay & Lesbian Times; 9/4/2008, Issue 1080, p23 

    The article discusses the data from city health department, which indicates that New York City residents are contracting HIV at three times the national rate.

  • Further fears of HIV in India.
    Jayaraman, K.S. // Nature; 2/9/1989, Vol. 337 Issue 6207, p496 

    Reports on an investigation launched in India after the chance discovery of HIV (human immunodeficiency virus) antibodies in a widely used product derived from donors' blood. Other HIV scares.

  • High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients.
    Pang, S.; Koyanagi, Y. // Nature; 1/4/1990, Vol. 343 Issue 6253, p85 

    Modifies the PCR method in order to study the amount and form of HIV-1 DNA primary tissue of AIDS patients. Methods; Results; Discussion.

  • Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek, T.D.; Lambert, D.M. // Nature; 1/4/1990, Vol. 343 Issue 6253, p90 

    Demonstrates that synthetic peptide analogues, which are potent inhibitors of purified HIV-1 protease, inhibit the processing of the viral polyproteins in cultures of HIV-1-infected T lymphocytes and attenuate viral infectivity. Methods; Results; Discussion.

  • HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor.
    McKeating, J.A.; Griffiths, P.D. // Nature; 2/15/1990, Vol. 343 Issue 6259, p659 

    Demonstrates that the Fc portion of immunoglobulins induced by cytomegalovirus allow immune complexes of human immunodeficiency virus (HIV) to infect fibroblasts otherwise not permissive to HIV infection. Methods; Results; Discussion.

  • Serine phosphorylation-independent down regulation of cell-surface CD4 by nef.
    Garcia, J.V.; Miller, A.D. // Nature; 4/11/1991, Vol. 350 Issue 6318, p508 

    Expresses the `nef' gene of human immunodeficiency virus type 1 (HIV-1) in three lymphocytic cell lines expressing CD4 using a Moloney murine leukemia virus-based retroviral vector. Experimental methods; Results; Discussion.

  • Do antibodies enhance the infection of cells by HIV?
    Bolognesi, D.P. // Nature; 8/10/1989, Vol. 340 Issue 6233, p431 

    Examines the mechanisms by which human immunodeficiency virus (HIV) can enter cells other than by the conventional mechanisms of attachment of HIV to CD4. Process.

  • A highly divergent HIV-2-related isolate.
    Dietrich, U.; Adamski, M. // Nature; 12/21/1989, Vol. 342 Issue 6252, p948 

    Describes a human immunodeficiency virus type 2 (HIV-2)-related isolate, HIV-2D205, from a healthy Ghanaian woman that is genetically equidistant to the prototypic HIV-2 strains and to sooty mangabey virus (SIVsm) and the simian immunodeficiency virus from rhesus macaques (SIVmac). Methods;...

  • Biological properties of a CD4 immunoadhesin.
    Byrn, R.A.; Mordenti, J. // Nature; 4/12/1990, Vol. 344 Issue 6267, p667 

    Demonstrates that a CD4 immunoadhesin can mediate antibody-dependent cell-mediated cytotoxicity towards human immunodeficiency virus (HIV)-infected cells. Methods; Results; Discussion.

  • Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly, T.J.; Cook, K.C. // Nature; 12/14/1989, Vol. 342 Issue 6251, p816 

    Demonstrates that the Rev protein, purified from `Escherichia coli,' binds in a sequence-specific manner to the Rev-responsive element in vitro. Methods; Results; Discussion.

  • Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
    Buonocore, L.; Rose, J.K. // Nature; 6/14/1990, Vol. 345 Issue 6276, p625 

    Demonstrates that expression of a soluble CD4 molecule, mutated to contain a specific retention signal for the endoplasmic reticulum, blocks secretion of gp120 and surface expression of gp120/41, but does not interfere with transport of wild-typeCD4.

  • Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate, C.; Zapp, M.L. // Nature; 6/14/1990, Vol. 345 Issue 6276, p640 

    Presents research reporting that HIV-1 Tat protein can activate transcription when bound to nascent RNA through the RNA-binding domain of another HIV-1 protein, Rev. Methods; Results; Discussion.

  • Rage and confusion hide role of HIV.
    Maddox, J. // Nature; 5/21/1992, Vol. 357 Issue 6375, p188 

    Reports that Dr. Peter Duesberg's argument that HIV is not the cause of AIDS did not gain any ground at a recent alternative AIDS conference. The small army of followers who believe in his message; Martien Brands, the originator of the conference; Apparent differences in data between the...

  • Trapped but still dangerous.
    Schrager, Lewis K.; Fauci, Anthony S. // Nature; 10/26/1995, Vol. 377 Issue 6551, p680 

    Reports on the sinister survival strategy of the human immunodeficiency virus (HIV) even in the presence of antibodies that would otherwise neutralize its infectivity. Factors implicated in the development of HIV-infected diseases; Extracellular t rapping of viral particles on follicular...

  • Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity.
    Braddock, M.; Thorburn, A.M. // Nature; 4/4/1991, Vol. 350 Issue 6317, p439 

    Demonstrates that Tat activation of its target RNA in the nucleus involves a Tat-dependent covalent modification. Also finds that the nucleoside analogue 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole blocks this Tat-dependent modification.

  • Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini, A.; Young, R.A. // Nature; 6/6/1991, Vol. 351 Issue 6326, p479 

    Reports that a variety of human immunodeficiency virus (HIV) type 1 polypeptides can be expressed in `Mycobacterium bovis' bacillus Calmette-Guerin (BCG) recombinants under the control of mycobacterial hsp70 promoter. Foreign polypeptides produced in BCG can induce antibody and T-cell responses.

  • Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression.
    Laurence, Jeffrey; Hodtsev, Andrew S. // Nature; 7/16/1992, Vol. 358 Issue 6383, p255 

    Presents evidence that human CD4 T-cell lines expressing selected T-cell antigen receptor V beta gene products can all be infected in vitro with HIV-1, but give markedly different titres of HIV-1 virion production. Pathogenesis of AIDS; More.

  • The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS.
    Anderson, R.; May, R.M. // Nature; 8/15/1991, Vol. 352 Issue 6336, p581 

    Examines the spread of the human immunodeficiency virus type 1 (HIV-1) in Africa. Epidemiology in Africa; Epidemiological parameters; Sexual behavior; Mathematical models; Discussion.

  • HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
    Bachelerie, F.; Alcamo, J. // Nature; 4/25/1991, Vol. 350 Issue 6320, p709 

    Demonstrates that chronic human immunodeficiency virus (HIV) infection results in both induction of a nuclear factor with antigenic properties indistinguishable from those of NF-kappa B and permanently increased HIV enhancer activity. This phenomenon is associated with HIV replication and may...

  • Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.
    Gao, Feng; Yue, Ling // Nature; 8/6/1992, Vol. 358 Issue 6386, p495 

    Relates that our understanding of the biology and origins of HIV-2 derives from studies of cultured isolates from urban populations experiencing epidemic infection and disease. Tests the hypothesis that such isolates might represent only a subset of a larger, more genetically diverse group of...

  • The crisis to come.
    Kaminski, Matthew; Palchikoff, Kim // Newsweek; 4/14/1997, Vol. 129 Issue 15, p44 

    Looks at the growing AIDS epidemic in the nations of the former Soviet Union. Prostitution and drug use helping to spread the disease; Lack of knowledge about HIV and AIDS in the former Soviet Union; Quality of medical care and facilities in the area; Estimated number of unreported cases of HIV...

  • How long does HIV survive?
    M.O.R. // Cortlandt Forum; 12/20/95, Vol. 8 Issue 12, p72 

    Focuses on how long the human immunodeficiency (HIV) virus survives outside the human body. Disinfectant for HIV.

  • Research presents hope for stopping HIV.
    M.O.R. // Modern Healthcare; 6/24/96, Vol. 26 Issue 26, p88 

    Reports on the optimism of researchers that the HIV virus can be eradicated. Discussion of clinical trials demonstrating viral suppression at a conference held in June 1996; Factors for researchers' optimism.

  • One-on-one.
    M.O.R. // Advocate; 12/12/95, Issue 696, p39 

    Presents advice on how actively HIV reproduces and the chances of developing AIDS. Design of tests that measure the amount of virus being produced by HIV-infected cells.

  • Court gives virus equal rights.
    M.O.R. // Human Events; 07/10/98, Vol. 54 Issue 26, p1 

    Reports on the court case Bragdon v. Abbott in the Supreme Court of the United States, in which a dentist was charged with violating the rights of a human immunodeficency virus (HIV) patient. Circumstances surrounding the case; Comments from Sidney Abbott, patient; Reference to the Americans...

  • AIDS and endocrinology.
    Laurence, Jeffrey // AIDS Patient Care & STDs; Oct97, Vol. 11 Issue 5, p317 

    Editorial. Presents information on the condition of some people after finding out that they are human immunodeficiency virus (HIV) positive. Comments from Doctor Anthony Fauci, director of the National Institute of Allergy and Immunology; Information on some complications of some recognized...

  • International AIDS society, USA panel-updates antireoviral therapy for 1997.
    Laurence, Jeffrey // AIDS Patient Care & STDs; Oct97, Vol. 11 Issue 5, p371 

    Reports on a study of the upgrade of a pathogenesis of human immunodeficiency virus (HIV) and the impact of the antiretroviral drug. Methodology used in the study; Results of the study; How HIV RNA has contributed in plasma; Discussion of study results.

  • Priority on HIV.
    Laurence, Jeffrey // Nature; 11/30/1989, Vol. 342 Issue 6249, p462 

    Opinion. Discusses a report in the `Chicago Tribune' by journalist John Crewdson concerning who first discovered the virus responsible for AIDS. Robert Gallo of the United States has been given too much credit and French researcher Montagnier too little credit. Report resurrects the...

Previous 50 Results Next 50 Results
Share

Buzz

Other Topics